Preclinical Drug Discovery & Toxicology
Facilitates target discovery and validation
The AQUA® platform provides unprecedented information about protein expression in tissue to advance personalized medicine. AQUA enables researchers to discover & validate new drug targets, Accelerate clinical development of safer & more effective targeted biotherapies
- Discover new protein biomarkers for disease detection, diagnosis, and treatment
- Identify potential new drug targets
- Monitor preclinical drug efficacy
- Develop & validate novel diagnostic reagents and tests corresponding to new biospecific therapeutics
- Validate animal models for similarities in protein pathways of human disease